Dongqin Xu

miR-124 downregulation leads to breast cancer progression via LncRNA-MALAT1 regulation and CDK4/E2F1 signal activation

Tongbao Feng, Fang Shao, Qiyong Wu et al. · Oncotarget · 2016 · 116 citations · Full text

Medicine, Genetics, Oncology +17

miR-124 inhibits cell proliferation in breast cancer through downregulation of CDK4

Tongbao Feng, Dongqin Xu, Chao Tu et al. · Tumor Biology · 2015 · 70 citations

Medicine, Cancer Biology, Oncology +16

β‐glucan restores tumor‐educated dendritic cell maturation to enhance antitumor immune responses

Yongling Ning, Dongqin Xu, Xiaohang Zhang et al. · International Journal of Cancer · 2016 · 54 citations · Full text

Medicine, Immunology, Oncology +17

Pentoxifylline attenuates nonalcoholic fatty liver by inhibiting hepatic macrophage polarization to the M1 phenotype

Dongqin Xu, Wenhao Zhao, Yiting Feng et al. · Phytomedicine · 2022 · 21 citations

Medicine, Pharmacology, Pharmacotherapy +11

Targeting macrophagic 17β-HSD7 by fenretinide for the treatment of nonalcoholic fatty liver disease

Xiaoyu Dong, Yiting Feng, Dongqin Xu et al. · Acta Pharmaceutica Sinica B · 2022 · 15 citations · Full text

Life Sciences, Biochemistry, Immunology +17